http://www.cnr.it/ontology/cnr/individuo/prodotto/ID23867
Multivariate analysis of prognostic factors and survival in patients with glioblastoma multiforme (Articolo in rivista)
- Type
- Label
- Multivariate analysis of prognostic factors and survival in patients with glioblastoma multiforme (Articolo in rivista) (literal)
- Anno
- 2008-01-01T00:00:00+01:00 (literal)
- Alternative label
Tramacere F, Gianicolo E, Serinelli M, Bambace S, De Luca M, Castagna R, Francavilla MC, Leone A, Monastero S, Fucilli F, Pili G, Distante A, Portaluri M. (2008)
Multivariate analysis of prognostic factors and survival in patients with glioblastoma multiforme
in La Clinica terapeutica (Roma, 2007, Online)
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Tramacere F, Gianicolo E, Serinelli M, Bambace S, De Luca M, Castagna R, Francavilla MC, Leone A, Monastero S, Fucilli F, Pili G, Distante A, Portaluri M. (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Note
- ISI Web of Science (WOS) (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- 1Unità Operativa di Radioterapia AUSL BR1, Ospedale Perrino, Brindisi;
2ISBEM (Euro Mediterranean Scientific BiomedicalInstitute), Brindisi;
3Università degli Studi di Bari;
4Unità Operativa Fisica Sanitaria BR1;
5Direttore Generale Istituto Oncologico IRCCS Bari, Italia (literal)
- Titolo
- Multivariate analysis of prognostic factors and survival in patients with glioblastoma multiforme (literal)
- Abstract
- Purpose. The aim of this study was to evaluate the survival of
patients with glioblastoma multiforme, to analyse the prognostic factors influencing the survival
datum and to review recent results in the literature.
Materials and Methods. Seventy five patients underwent radiation treatment between May 1998 and
April 2003. Among the factors under investigation we ascertained that sex, chemotherapy, conformal
treat- ment, surgery, and the choice of the irradiation area (whole brain or only the involved
field) did not influence the survival in a statistically significant manner.
Results. Whereas age and total dose were the 95% statistically significant variables. Hazard ratio
of patients older than 58 years compared to younger patients was 1.69. The death risk was 69% in
older than younger patients. A greater irradiation dose improved the survival with an increase of
the median survival days. The total dose lower than 6000 cGy caused an increase of 81.8% in the
death risk. The median survival from the diagnosis to the death was 14.7 months (446 days) and 1-,
2- and 3- year survival rate was 69.3%, 38.4%, and
14.7% respectively.
Conclusions. The current medical literature and our experience attests that the use of temozolomide
improves the survival of these
patients. (literal)
- Prodotto di
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Autore CNR di
- Prodotto
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Insieme di parole chiave di